Transplant Services is made up of an elite group of surgeons, headed by Göran B. Klintmalm, MD, Ph.D., FACS, Chairman and Chief of Annette C. and Harold C. Simmons Transplant Institute. Established in 1984, Transplant Services, who works in collaboration with Annette C. and Harold C. Simmons Transplant Institute, is one of the Top 10 centers in the nation. In conjunction with the Transplant Institute, we also work closely with Baylor Liver and Pancreas Disease Center and Liver Consultants of Texas.
We offer comprehensive treatments for liver, kidney, pancreas, and islet transplantation. With more than 6,000 successful solid organs, bone and marrow transplants, we have established a reputation for excellence and innovation in patient care and research. We are proud to participate in more than 60 research protocols and have trained more than 47 transplant surgeons who are now operating worldwide. Our surgeons provide transplant services at two locations, Baylor University Medical Center at Dallas and Baylor Scott & White All Saints Fort Worth.
Dr. Giuliano Testa and the team at Baylor performs first living-donor womb transplant in the US.
Baylor participates in the momentous unplanned event transplanting 12 organs in 24 hours, in turn giving nine patients the gift of life. Read More
As of February 2016, Baylor becomes the third hospital in the US to transplant 4,000 livers, including more than 55 living liver transplants - only the third program in the US to have done so.
January 26 - 29, 2017: Our surgeons attended the American Society of Transplant Surgeons (ASTS) State of the Art Winter Symposium in Miami, FL. As more patients suffer due to the shortage of life-saving donor organs each year, the ASTS focused its Winter Symposium on innovative science and effective public policy to combat this crisis.
March 3 -5, 2017: The University of Colorado hosted a conference to address controversial topics in transplantation, paired kidney transplantation, pancreas transplantation for diabetes, compensation for organ donation, immunosuppressive strategies, transplanting the sickest patient, new and emerging treatments for HCV.